Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check7 days agoChange DetectedThe page shows a revision label update from v3.4.2 to v3.4.3. This is a minor site version update and does not alter the study information.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2 with no substantive changes to study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page now shows Revision: v3.4.1, and the previous government-funding notices (lapse) and Revision: v3.4.0 have been removed.SummaryDifference0.3%

- Check43 days agoChange DetectedA new informational banner about a lapse in government funding and NIH operations was added at the top of the page, with links to cc.nih.gov and opm.gov.SummaryDifference0.3%

- Check50 days agoChange DetectedThe page updates are minor UI and metadata changes: a new 'Show glossary' option, updated QC-related labels (Last Update Submitted that Met QC Criteria), a new 'No FEAR Act Data' label, and a revised version tag (Revision: v3.4.0), with the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3; no evident changes to study content or data.SummaryDifference0.0%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.